Coronary stent SEQUENCE™

metaldrug eluting

SIROLIMUS ELUTING CORONARY STENT SYSTEM The combination of Sirolimus antiproliferative action combined with biodegradable polymer and a proven balloon catheter sets new standards in treatment of clinically complex lesions. Carrier coating and drug are absorbed simultaneously within three months, which covers exactly the time where restenosis tend to occur most frequently. Only a stent platform treated with inert carbon technology is left behind preventing any leakage of metals and avoiding allergic immune response reactions to stent implantation. HIGHLIGHTS Sirolimus-eluting Completely bioabsorbable within 3 months No auxiliary polymer used Reliable and even drug release No leakage of heavy metal ions Inhibition of thrombin synthesis Low inflation pressures Uniform stent expansion Optimal hydrophilic coating for maximized crossability High radial strength combined with high flexibility due to Open Cell design Carbon implanted stent surface for proven higher biocompatibility and highly reduced restenosis rate